MedTrace Logo

Impact of Exercise Prescription on Obstetric and Neonatal Outcomes

NCT07678944 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 310

Last updated 2026-07-02

No results posted yet for this study

Summary

The aim of this study is to assess the impact of structured physical activity with smartwatch remote monitoring on glycemic control, blood pressure control, obstetric complications and neonatal outcomes in women with GDM, chronic hypertension and obesity. A prospective, longitudinal, single-arm intervention study with 310 pregnant women was conducted over a period of 18 months. Participants received individualized exercise prescriptions based on international guidelines, complemented by smartwatch monitoring and regular telephonic feedback. Outcomes were compared between subgroups of women who adhere to the recommended exercise guidelines and those who did not, across three high-risk populations (GDM, chronic hypertension and obesity).

Conditions

  • Hypertension ,Pregnancy
  • Diabetes During Pregnancy
  • Obesity (BMI>30)

Interventions

BEHAVIORAL

Physical activity plan

pregnant women who engaged in a physical activity routine previously prescribed

BEHAVIORAL

Women who received information but did not engaged in a physical activity routine

No structured physical activity

Sponsors & Collaborators

  • Unidade Local de Saúde de Coimbra, EPE

    lead OTHER

Principal Investigators

  • Filipa M Coutinho, MD · Unidade Local de Saúde de Coimbra, EPE

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2025-02-01
Completion
2025-08-01

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07678944 on ClinicalTrials.gov